BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 12695743)

  • 1. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
    Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
    Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
    Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
    Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
    Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats.
    Asakura H; Okudaira M; Yoshida T; Ontachi Y; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Thromb Haemost; 2002 Oct; 88(4):663-7. PubMed ID: 12362240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats.
    Asakura H; Suga Y; Aoshima K; Ontachi Y; Mizutani T; Kato M; Saito M; Morishita E; Yamazaki M; Takami A; Miyamoto K; Nakao S
    Crit Care Med; 2002 Jan; 30(1):161-4. PubMed ID: 11902257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reproduction of a rat model of disseminated intravascular coagulation accompanied by multiple organ injuries].
    Qiao YJ; Zhu JM; Zhang Y; Yuan HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):41-3. PubMed ID: 17207364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
    Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
    Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Semin Thromb Hemost; 1996; 22(3):255-9. PubMed ID: 8836010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid.
    Asakura H; Sano Y; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Haematologica; 2004 Jun; 89(6):757-8. PubMed ID: 15194548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist.
    Suga Y; Asakura H; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Nakao S; Miyamoto K
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):593-8. PubMed ID: 15389127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
    Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S
    Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
    Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    BregengÄrd C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed exploration of pathophysiology involving inflammatory status and bleeding symptoms between lipopolysaccharide- and tissue factor-induced disseminated intravascular coagulation in rats.
    Suga Y; Kubo A; Katsura H; Staub Y; Tashiro K; Yamada S; Morishita E; Asakura H
    Int J Hematol; 2021 Aug; 114(2):172-178. PubMed ID: 33907978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia.
    Chen HW; Kuo HT; Chai CY; Ou JL; Yang RC
    J Endotoxin Res; 2007; 13(1):15-23. PubMed ID: 17621542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Ichino T; Yoshida T; Suga Y; Ontachi Y; Mizutani T; Kato M; Ito T; Yamazaki M; Aoshima K; Morishita E; Saito M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):233-9. PubMed ID: 11943937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
    Yun-Choi HS; Pyo MK; Chang KC; Lee DH
    Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model.
    Olrik Berthelsen L; Thuri Kristensen A; Wiinberg B; Tranholm M
    Thromb Res; 2009 Sep; 124(4):490-7. PubMed ID: 19525002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.